Intech Investment Management LLC Has $6.07 Million Holdings in CVS Health Co. (NYSE:CVS)

Intech Investment Management LLC raised its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 70.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 96,520 shares of the pharmacy operator's stock after buying an additional 39,919 shares during the quarter. Intech Investment Management LLC's holdings in CVS Health were worth $6,069,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the business. Payden & Rygel bought a new position in shares of CVS Health during the 3rd quarter valued at about $6,282,000. Pzena Investment Management LLC lifted its holdings in shares of CVS Health by 1.5% during the 3rd quarter. Pzena Investment Management LLC now owns 13,135,308 shares of the pharmacy operator's stock valued at $825,948,000 after purchasing an additional 198,920 shares in the last quarter. Advisors Asset Management Inc. lifted its holdings in shares of CVS Health by 35.1% during the 3rd quarter. Advisors Asset Management Inc. now owns 133,666 shares of the pharmacy operator's stock valued at $8,405,000 after purchasing an additional 34,728 shares in the last quarter. Segall Bryant & Hamill LLC bought a new position in shares of CVS Health during the 3rd quarter valued at about $1,847,000. Finally, West Family Investments Inc. lifted its holdings in shares of CVS Health by 13.6% during the 3rd quarter. West Family Investments Inc. now owns 24,992 shares of the pharmacy operator's stock valued at $1,571,000 after purchasing an additional 2,986 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Trading Up 1.6 %

CVS Health stock traded up $0.91 during trading hours on Friday, hitting $58.01. The stock had a trading volume of 11,153,900 shares, compared to its average volume of 12,620,673. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The stock has a market cap of $73.00 billion, a price-to-earnings ratio of 14.72, a P/E/G ratio of 0.96 and a beta of 0.55. CVS Health Co. has a one year low of $52.71 and a one year high of $83.25. The business's 50 day simple moving average is $59.21 and its 200-day simple moving average is $58.59.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business's quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the company earned $2.21 earnings per share. On average, equities analysts predict that CVS Health Co. will post 5.43 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.59%. CVS Health's dividend payout ratio is currently 67.51%.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. Cantor Fitzgerald restated a "neutral" rating and issued a $62.00 target price on shares of CVS Health in a research note on Tuesday, October 1st. StockNews.com cut CVS Health from a "hold" rating to a "sell" rating in a research note on Thursday, November 14th. Barclays cut their target price on CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a research note on Thursday, November 7th. Truist Financial restated a "buy" rating and issued a $67.00 target price (down previously from $76.00) on shares of CVS Health in a research note on Wednesday. Finally, Mizuho cut their target price on CVS Health from $73.00 to $66.00 and set an "outperform" rating on the stock in a research note on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat, CVS Health has an average rating of "Moderate Buy" and an average target price of $72.28.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.